Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Neoplasm by Special Category — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category

Other

Neoplasm by Special Category

CI-CAN-00000004Explore in graph →

Non-malignant21,340 active trials259 approved drugs3,859 evidence items

NCIt: C7062

Overview
Statistics
Survival
Genomics477
Variants & evidence3859
Drugs429
Trials95701
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

95,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 40,391 Unknown 15,060 Recruiting 15,050 Terminated 9,281 Active Not Recruiting 6,483 Not Yet Recruiting 4,833 Withdrawn 3,358 Enrolling By Invitation 481 Suspended 429 No Longer Available 172 Approved For Marketing 79 Available 75 Temporarily Not Available 9

PhaseAll Early Phase 1 1,589 N/A 18,134 Phase 1 21,292 Phase 2 34,076 Phase 3 8,550 Phase 4 1,547

No study matches these filters